Derik De Bruin Analyst Performance

Managing Director, Life Sciences Tools & Diagnostics Analyst at Bank of America

Derik De Bruin is a stock analyst at Bank of America focused in the medical sector, covering 26 publicly traded companies. Over the past year, Derik De Bruin has issued 13 stock ratings, including buy, hold, and sell recommendations. While full access to Derik De Bruin's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Derik De Bruin's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

57 Last 10 Years

Buy Recommendations

50.88% 29 Buy Ratings

Companies Covered

26 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	50.9%	29 ratings
Hold	35.1%	20 ratings
Sell	14.0%	8 ratings

Out of 57 total stock ratings issued by Derik De Bruin at Bank of America, the majority (50.9%) have been Buy recommendations, followed by 35.1% Hold and 14.0% Sell.

Best & Worst Calls

• Best Call

  0000.0%

  EXAS

  Aug 2018

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  CPHD

  Dec 2014

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NYSE	50.0% of companies on NYSE	13 companies
NASDAQ	50.0% of companies on NASDAQ	13 companies

Derik De Bruin, an analyst at Bank of America, currently covers 26 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 24 companies	92.3%
	Computer and Technology 1 company	3.8%
	Miscellaneous 1 company	3.8%

Derik De Bruin of Bank of America specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 7 companies	26.9%
MED INSTRUMENTS 4 companies	15.4%
MEDICAL SERVICES 3 companies	11.5%
MED PRODUCTS 2 companies	7.7%
MED/DENTAL - SUPP 2 companies	7.7%
INSTRU - SCIENTFC 1 company	3.8%
MEDICAL INFO SYS 1 company	3.8%
MED - OUTP/HM CRE 1 company	3.8%
MED - GENERIC DRG 1 company	3.8%
ANALYTICAL INSTRUMENTS 1 company	3.8%
PHARMACEUTICAL PREPARATIONS 1 company	3.8%
MEDICAL LABORATORIES 1 company	3.8%
Miscellaneous 1 company	3.8%

Derik De Bruin's Ratings History at Bank of America

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
MTD Mettler-Toledo International	9/22/2025	Boost Price Target	$1,255.78	$1,390.00	Neutral	$0.00 00.00% ROI
DHR Danaher	9/22/2025	Lower Price Target	$190.91	$220.00	Buy	$0.00 00.00% ROI
PAHC Phibro Animal Health	8/29/2025	Boost Price Target	$36.88	$27.00	Underperform	$0.00 00.00% ROI
RVTY Revvity	6/26/2025	Lower Price Target	$98.48	$110.00	Buy	$0.00 00.00% ROI
BRKR Bruker	6/26/2025	Lower Price Target	$41.96	$50.00	Buy	$0.00 00.00% ROI
TXG 10x Genomics	6/26/2025	Boost Price Target	$11.43	$13.00	Neutral	$0.00 00.00% ROI
QGEN Qiagen	6/26/2025	Boost Price Target	$47.84	$53.00	Buy	$0.00 00.00% ROI
MTD Mettler-Toledo International	6/26/2025	Boost Price Target	$1,189.86	$1,260.00	Neutral	$0.00 00.00% ROI
WAT Waters	6/26/2025	Boost Price Target	$354.15	$375.00	Neutral	$0.00 00.00% ROI
MYGN Myriad Genetics	3/3/2025	Lower Price Target	$10.73	$11.00	Underperform	$0.00 00.00% ROI
EXAS Exact Sciences	2/20/2025	Lower Price Target	$50.48	$65.00	Buy	$0.00 00.00% ROI
NEO NeoGenomics	2/19/2025	Lower Price Target	$12.40	$16.00	Neutral	$0.00 00.00% ROI
WAT Waters	2/13/2025	Lower Price Target	$382.45	$410.00	Neutral	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.